Hyben Vital ApS   Report issue

For profit Phase 3
Founded: Langeland Denmark (1981)
Status: No NME R&D (1981)

Organization Overview

First Clinical Trial
2011
NCT01459939
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2011

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 3 Trials (1)

rosehip (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Common Cold (Phase 3)

Osteoarthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 2
  • # of Trial APIs: 1